动脉发生
血运重建
血管生成
生物
促炎细胞因子
基质细胞蛋白
免疫学
巨噬细胞
血管内皮生长因子
衰老
癌症研究
医学
炎症
内科学
细胞生物学
细胞外基质
血管内皮生长因子受体
体外
生物化学
心肌梗塞
作者
Minghong Chen,Junyu Chen,Yu Liu,Xuerui Wang,Meilian Yao,Jing Chen,Jian Zhang,Qun Huang
出处
期刊:Aging Cell
[Wiley]
日期:2025-04-17
卷期号:24 (7): e70059-e70059
被引量:10
摘要
Peripheral arterial disease is a common vascular disease in the elderly. Therapeutic revascularization, including angiogenic and arteriogenic therapy, is a promising treatment approach for peripheral arterial disease. However, the progress of clinical trials is not ideal, possibly due to insufficiency of preclinical models, such as not taking into account the effect of aging on vascular regeneration. Macrophages are crucial in angiogenesis and arteriogenesis. The aging microenvironment typically makes recruited monocytes and macrophages more susceptible to senescence. However, the feature of macrophages in ischemic hindlimb muscle of old individuals and their underlying role remains unclear. In this study, we reveal that macrophages of ischemic skeletal muscle in old mice are more senescent and proinflammatory. By transplanting macrophages into mice following hindlimb ischemia, we find senescent macrophages inhibit revascularization. Mechanistically, these senescent macrophages induce endothelial dysfunction via increasing vascular endothelial growth factor A-165B (VEGF-A165B) expression and secretion, and eventually impair revascularization. Notably, plasma VEGF-A165B levels are elevated in old patients with PAD and positively associated with a lower ankle brachial index (ABI). Our study suggests that targeting the senescent macrophages presents an avenue to improve age-related revascularization damage.
科研通智能强力驱动
Strongly Powered by AbleSci AI